Prospects for the Use of Donor Blood in a Cardiac Surgery Clinic
Investigation of problems of infection among patients with heart diseaseand blood donors, diagnosisand detection of serological markers of hepatitis B, C, syphilis, HIV infection and alternative development of free donation.
The aim. To analyze the dynamics of serotypes of infections in patients and donors in recent years, and to determine the prospects of free donation in a cardiac surgery clinic.
Materials and methods. The study was performed by means of detection of hepatitis B, hepatitis C, syphilis and HIV infection markers in 19,965 patients with heart diseases and 9,502 donors in 2017-2019, and included analysis of the development of voluntary blood donation in Ukraine.
Results. In 2017-2019, a 4-fold increase in the total amount of donated blood was noted due to the development of Voluntary Blood Donation (VBD) program. In patients with heart diseases requiring surgical treatment, the average rate of infection in this period was 5.76%. Among blood donors in those years, there was a notable increase in serological markers of syphilis (5.3-fold) and HIV infection (2.3-fold). In the process of examination and procurement of donated blood, the lack of donor blood from relatives of patients is 27%, and the lack of blood from voluntary donors is 17%.
Conclusion. Increase in the amount of donated blood thanks to the first-time donors in the VBD program requires careful laboratory monitoring to detect antibodies to the causative agents of syphilis, hepatitis B, C and HIV, as well as mandatory post-quarantine laboratory monitoring of donor plasma.
- Kitchen AD, Barbara JA. Current Information on the Infectious Risks of Allogeneic Blood Transfusion. Transfusion Alter Transfusion Med. 2008;10(3):102-11. https://doi.org/10.1111/j.1778-428X.2008.00112.x
- Seighali F, Hosseini Divkolaye NS, Koohi E, Pourfathollah AA, Rahmani AM. The status of blood safety in ECO member states. Blood Transfus. 2015 Oct;13(4):583-7. https://doi.org/10.2450/2015.0035-15
- Gural AL, Krishtof AL, Shaginian VR. [Optimization of virus protection in blood service]. Laboratory Diagnostics. 2004;3:3-11. Ukrainian.
- Khubutiya MS, Solonin SA, Bazhenov AI, Kobzeva EN, Smirnova YuV, Godkov MA. [Risks of transmission blood-borne viral infections via blood transfusion, organ and tissue transplantation]. Transplantologiya. The Russian Journal of Transplantation. 2015;(4):23-33.Russian.
- Lindholm A. Epidemiology of viral infections in the Swedish blood-donor population. Blood Coagul. Fibrinolysis. 1994 Dec; 5 Suppl 3: S 13-7; discussion S 19. https://doi.org/10.1097/00001721-199412003-00004
- Frazier SK, Higgins J, Bugajski A, Jones AR, Brown MR. Adverse Reactions to Transfusion of Blood Products and Best Practices for Prevention. Crit Care Nurs Clin North Am. 2017 Sep;29(3):271-290. https://doi.org/10.1016/j.cnc.2017.04.002
- Timler D, Klepaczka J, Kasielska-Trojan A, Bogusiak K. Analysis of complications after blood components’ transfusions. Pol Przegl Chir. 2015 Apr;87(4):166-73. https://doi.org/10.1515/pjs-2015-0039. PMID: 26146115
- Kato H, Nakayama T, Uruma M, Okuyama Y, Handa M, Tomiyama Y, et al. Repeated exposure rather than the total volume of transfused components may influence the incidence of allergic transfusion reactions. Transfusion. 2015 Nov;55(11):2576-81. https://doi.org/10.1111/trf.13201